Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +2.86% rose 1.38% to $158.08 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.22% falling 1.18% to 4,513.04 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.19% falling 1.34% to 34,022.04. Johnson & Johnson closed $21.84 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +1.46% rose 3.79% to $399.59, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.80% fell 0.63% to $74.44, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.94% rose 1.77% to $54.68. Trading volume (9.8 M) eclipsed its 50-day average volume of 7.0 M.